Business Description
Annovis Bio Inc
NAICS : 325411
SIC : 2833
ISIN : US03615A1088
Description
Financial Strength
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | No Debt | |||||
Equity-to-Asset | -0.35 | |||||
Piotroski F-Score | 2/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | -79.1 | |||||
3-Year EPS without NRI Growth Rate | -78.4 | |||||
3-Year FCF Growth Rate | -91.7 | |||||
Future 3-5Y EPS without NRI Growth Rate | 28.56 |
Momentum Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 57.52 | |||||
9-Day RSI | 53.41 | |||||
14-Day RSI | 50.62 | |||||
6-1 Month Momentum % | -32.5 | |||||
12-1 Month Momentum % | -12.8 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.24 | |||||
Quick Ratio | 1.24 | |||||
Cash Ratio | 0.99 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -15.1 | |||||
Shareholder Yield % | -7.46 |
Profitability Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROE % | -1478.76 | |||||
ROA % | -383.35 | |||||
ROIC % | -1843.22 | |||||
ROC (Joel Greenblatt) % | -1843.22 | |||||
ROCE % | -548.54 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
EV-to-EBIT | -2.47 | |||||
EV-to-Forward-EBIT | -3.25 | |||||
EV-to-EBITDA | -2.47 | |||||
EV-to-Forward-EBITDA | -2.3 | |||||
EV-to-FCF | -3.59 | |||||
Earnings Yield (Greenblatt) % | -40.45 | |||||
FCF Yield % | -27.72 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
Annovis Bio Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | |||
EPS (TTM) (€) | -4.165 | ||
Beta | 2.5 | ||
Volatility % | 180.28 | ||
14-Day RSI | 50.62 | ||
14-Day ATR (€) | 0.24133 | ||
20-Day SMA (€) | 7.354 | ||
12-1 Month Momentum % | -12.8 | ||
52-Week Range (€) | 4.42 - 18.1 | ||
Shares Outstanding (Mil) | 13.05 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 2 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Annovis Bio Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Annovis Bio Inc Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
Annovis Bio Inc Frequently Asked Questions
What is Annovis Bio Inc(FRA:07X)'s stock price today?
When is next earnings date of Annovis Bio Inc(FRA:07X)?
Does Annovis Bio Inc(FRA:07X) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |